Tietze’s Syndrome and Breast Cancer Treatment
HER2-positive breast cancer poses a significant challenge in oncology. Novel therapies seek to improve survival rates. Kanjinti is a promising option. Understanding its role requires evaluating its efficacy and interactions with other conditions. How does it perform alongside other treatments?...